Post-mRNA COVID-19 Vaccination Myocarditis
KeywordsCOVID-19, myocarditis, COVID-19 vaccine
A new trend of myocarditis among young adults who received mRNA vaccines for COVID-19 is emerging. We present the case of a young adult who presented with chest pain 3 days after the second dose of Pfizer-BioNTech COVID-19 vaccine. He had elevated troponin I and C-reactive protein levels at the time of admission. Electrocardiogram (ECG) and echocardiogram findings were unremarkable. The patient improved with conservative management and was discharged home the next day.
Issue: 2021: Vol 8 No 8 (view)